The Combining Ability of Glycoproteins IIb, IIIa and Ca²⁺ in EDTA-Treated Nonaggregable Platelets

Summary

Platelets deprived of calcium and incubated at 37° C for 10 min lose their ability to bind fibrinogen or aggregate with ADP when adequate concentrations of calcium are restored. Since the calcium complex of glycoproteins (GP) IIb and IIIa is the presumed receptor for fibrinogen, it seemed appropriate to examine the behavior of these glycoproteins in incubated non-aggregable platelets. No differences were noted in the electrophoretic pattern of nonaggregable EDTA-treated and aggregable control CaEDTA-treated platelets when SDS gels of Triton X- 114 fractions were stained with silver. GP IIb and IIIa were extracted from either nonaggregable EDTA-treated platelets or aggregable control platelets with calcium-Tris-Triton buffer and subjected to sucrose density gradient centrifugation or crossed immunoelectrophoresis. With both types of platelets, these glycoproteins formed a complex in the presence of calcium. If the glycoproteins were extracted with EDTA-Tris-Triton buffer, or if Triton-solubilized platelet membranes were incubated with EGTA at 37° C for 30 min, GP IIb and IIIa were unable to form a complex in the presence of calcium. We conclude that inability of extracted GP IIb and IIIa to combine in the presence of calcium is not responsible for the irreversible loss of aggregability that occurs when whole platelets are incubated with EDTA at 37° C.

Keywords

Platelet aggregation - Glycoproteins IIb and IIIa - EDTA

• References

• 1 Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401
• 2 Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-5363
• 3 Peerschke EI, Zucker MB, Grant RA, Egan JJ, Johnson MM. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 1980; 55: 841-847
• 4 Hawiger JS, Parkinson S, Timmons S. Prostacyclin inhibits mobiliza-tion of fibrinogen-binding sites on human ADP- and thrombin- treated platelets. Nature 1980; 283: 195-197
• 5 Komecki E, Niewiarowski S, Morinelli TA, Kloczewiak M. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrino-gen receptors on normal human and Glanzmann’s thrombasthenic platelets. J Biol Chem 1981; 256: 5696-5701
• 6 Peerschke EI, Zucker MB. Fibrinogen receptor exposure and aggregation of human blood platelets produced by ADP and chilling. Blood 1981; 57: 663-670
• 7 Mustard JF, Kinlough-Rathbone RL, Packham MA, Perry DW, Harfenist EJ, Pai KR M. Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymo-trypsin. Blood 1979; 54: 987-993
• 8 Zucker MB, Pert JH, Hilgartner MW. Platelet function in a patient with thrombasthenia. Blood 1966; 28: 524-534
• 9 Weiss HJ, Kochwa S. Studies of platelet function and proteins in 3 patients with Glanzmann’s thrombasthenia. J Lab Clin Med 1968; 71: 153-165
• 10 Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 1974; 28: 253-260
• 11 Phillips DR, Jenkins CS, Luscher EF, Larrieu M-J. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 1975; 257: 599-600
• 12 Shulman S, Karpatkin S. Crossed immunoelectrophoresis of human platelet membranes Diminished major antigen in Glanzmann’s thrombasthenia and Bernard-Soulier syndrome. J Biol Chem 1980; 255: 4320-4327
• 13 Hagen I, Bjerrum O, Gogstad G, Korsmo R, Solum NO. Involvement of divalent cations in the complex between the platelet glycoproteins IIb and IIIa. Biochim Biophys Acta 1982; 701: 1-6
• 14 Kunicki TJ, Pidard D, Rosa JP. The formation of Ca⁺⁺-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by cross immunoelectrophoresis. Blood 1981; 58: 268-278
• 15 Howard L, Shulman S, Sadanadan S, Karpatkin S. Crossed immunoelectrophoresis of human platelet membranes. The major antigen consists of a complex of glycoproteins, GP lib and GP Ilia, held together by Ca²⁺and missing in Glanzmann’s thrombasthenia J Biol Chem 1982; 257: 8331-8336
• 16 Jennings LK, Phillips DR. Purification of glycoproteins IIb and III from human platelet plasma membranes and characterization of a calcium-dependent glycoprotein IIb-III complex. J Biol Chem 1982; 257: 10458-10466
• 17 Nachman RL, Leung LL K. Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest 1982; 69: 263-269
• 18 Gogstad GO, Brosstad F, Krutnes M-B, Hagen I, Solum NO. Fibrinogen-binding properties of the human platelet glycoprotein IIb-IIIa complex: a study using crossed-radioimmunoelectrophoresis. Blood 1982; 60: 663-671
• 19 McEver RP, Bennett EM, Martin MN. Identification of two structurally and functionally distinct sites on human platelet mem-brane glycoproteins Ilb-IIIa using monoclonal antibodies. J Biol Chem 1983; 258: 5269-5257
• 20 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72: 325-338
• 21 Coller BS, Peerschke EI, Nurden AT, Rosa J-P. The epitope of a monoclonal antibody that inhibits fibrinogen binding to platelets is EDTA-sensitive: implications for the presence of the GPIIb/IIIa complex on unactivated platelets. Thromb Haemostas 1983; 50: 314 (Abstr.)
• 22 Bennett JS, Hoxie JA, Lehman SF, Vilaire G, Cines DB. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci USA 1983; 80: 4217-2421
• 23 Zucker MB, Grant RA. Nonreversible loss of platelet aggregability induced by calcium deprivation. Blood 1978; 52: 505-514
• 24 Taylor PM, Heptinstall S. The abilities of human blood platelets to bind extracellular calcium and to be aggregated by adenosine diphos-phate are related. Br J Haematol 1980; 46: 115-122
• 25 Zucker MB, Masiello NC. Platelet aggregation caused by dithiothreitol. Thromb Haemostas 1983. (in press)
• 26 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
• 27 Morrissey JH. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981; 117: 307-310
• 28 Zucker MB, Masiello NC. The Triton X-100 insoluble residue (“cytoskeleton”) of aggregated platelets contains increased lipid phosphorus as well as ¹²⁵I-labeled glycoproteins. Blood 1983; 64: 676-683
• 29 Peerschke EI, Grant RA, Zucker MB. Decreased association of ⁴⁵Calcium with platelets unable to aggregate due to thrombasthenia or prolonged calcium deprivation. Br J Haematol 1980; 46: 247-256
• 30 Brass LF, Shattil SJ. Deficiency of high affinity binding sites for Ca⁺⁺on Glanzmann’s thrombasthenia platelets. Blood 1982; 60: 195 a
• 31 Johnston GI, Taylor PM, Heptinstall S. Studies on platelets from patients with Glanzmann’s thrombasthenia suggest that the surface- located Ca-binding sites that are relevant to platelet aggregation are associated with glycoproteins IIb and IIIa. Thromb Haemostas 1983; 50: 215 (Abstr.)